US Patent Issued to The Board of Trustees of the Leland Stanford Junior University on Dec. 30 for "Use of annexin V as a method to block tumor induced immunosuppression of the innate immune response" (California Inventor)

ALEXANDRIA, Va., Dec. 31 -- United States Patent no. 12,508,296, issued on Dec. 30, was assigned to The Board of Trustees of the Leland Stanford Junior University (Stanford, Calif.).

"Use of annexin V as a method to block tumor induced immunosuppression of the innate immune response" was invented by Francis G. Blankenberg (Portola Valley, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods are provided for treating a subject with cancer, with a therapeutic dose of annexin V to the subject."

The patent was filed on Jan. 12, 2022, under Application No. 17/574,223.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=...